1. Home
  2. GKOS vs CLBT Comparison

GKOS vs CLBT Comparison

Compare GKOS & CLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CLBT
  • Stock Information
  • Founded
  • GKOS 1998
  • CLBT 1999
  • Country
  • GKOS United States
  • CLBT Israel
  • Employees
  • GKOS N/A
  • CLBT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CLBT Computer Software: Prepackaged Software
  • Sector
  • GKOS Health Care
  • CLBT Technology
  • Exchange
  • GKOS Nasdaq
  • CLBT Nasdaq
  • Market Cap
  • GKOS 5.1B
  • CLBT 4.6B
  • IPO Year
  • GKOS 2015
  • CLBT N/A
  • Fundamental
  • Price
  • GKOS $89.91
  • CLBT $19.84
  • Analyst Decision
  • GKOS Strong Buy
  • CLBT Strong Buy
  • Analyst Count
  • GKOS 13
  • CLBT 7
  • Target Price
  • GKOS $135.15
  • CLBT $23.43
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • CLBT 816.0K
  • Earning Date
  • GKOS 04-30-2025
  • CLBT 05-14-2025
  • Dividend Yield
  • GKOS N/A
  • CLBT N/A
  • EPS Growth
  • GKOS N/A
  • CLBT N/A
  • EPS
  • GKOS N/A
  • CLBT N/A
  • Revenue
  • GKOS $404,523,000.00
  • CLBT $401,203,000.00
  • Revenue This Year
  • GKOS $27.84
  • CLBT $23.09
  • Revenue Next Year
  • GKOS $27.88
  • CLBT $17.61
  • P/E Ratio
  • GKOS N/A
  • CLBT N/A
  • Revenue Growth
  • GKOS 23.92
  • CLBT 23.41
  • 52 Week Low
  • GKOS $77.10
  • CLBT $10.25
  • 52 Week High
  • GKOS $163.71
  • CLBT $26.30
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • CLBT 54.94
  • Support Level
  • GKOS $84.26
  • CLBT $18.78
  • Resistance Level
  • GKOS $92.27
  • CLBT $20.53
  • Average True Range (ATR)
  • GKOS 3.94
  • CLBT 0.55
  • MACD
  • GKOS 0.57
  • CLBT 0.01
  • Stochastic Oscillator
  • GKOS 58.87
  • CLBT 71.01

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Share on Social Networks: